Pep‐Lipid Cubosomes and Vesicles Compartmentalized by Micelles from Self‐Assembly of Multiple Neuroprotective Building Blocks Including a Large Peptide Hormone PACAP‐DHA. Issue 11 (25th September 2019)
- Record Type:
- Journal Article
- Title:
- Pep‐Lipid Cubosomes and Vesicles Compartmentalized by Micelles from Self‐Assembly of Multiple Neuroprotective Building Blocks Including a Large Peptide Hormone PACAP‐DHA. Issue 11 (25th September 2019)
- Main Title:
- Pep‐Lipid Cubosomes and Vesicles Compartmentalized by Micelles from Self‐Assembly of Multiple Neuroprotective Building Blocks Including a Large Peptide Hormone PACAP‐DHA
- Authors:
- Angelova, Angelina
Drechsler, Markus
Garamus, Vasil M.
Angelov, Borislav - Abstract:
- Abstract: Structural control over design and formation of self‐assembled nanomaterials for neuroprotection and neuroregeneration is crucial for their application in nanomedicine. Here a synthetic construct of the pituitary adenylate cyclase‐activating polypeptide (PACAP38) coupled to a docosahexaenoic acid (DHA: an ω‐3 polyunsaturated fatty acid (PUFA)) is designed towards the creation of compartmentalized liquid crystalline assemblies of neuroprotective compounds. The hormone PACAP38 is a ligand of the class B PAC1 G‐protein‐coupled receptor (GPCR), whereas DHA is a lipid trophic factor. The lipidated peptide PACAP‐DHA is co‐assembled into hierarchical nanostructures elaborated from hybrid vesicle‐micelle reservoirs as well into PEGylated cubosomes composed of multiple neuroprotective building blocks. The resulting nanostructures are determined by synchrotron small‐angle X‐ray scattering (BioSAXS) and cryogenic transmission electron microscopy (cryo‐TEM). Multicompartment topologies are obtained in a two‐fold approach: (i) intriguing compartmentalized vesicles, which embed pep‐lipid micelles forming nanopatterns, and (ii) multidomain pep‐lipid cubosomes. Both kinds of topologies are favorable for sustained‐release applications in combination therapies of neurodegeneration. The organizational complexity of the scaffolds involving the lipidated high‐molecular weight peptide hormone is beyond the one that has been reached with small lipid‐like peptide surfactants. Abstract :Abstract: Structural control over design and formation of self‐assembled nanomaterials for neuroprotection and neuroregeneration is crucial for their application in nanomedicine. Here a synthetic construct of the pituitary adenylate cyclase‐activating polypeptide (PACAP38) coupled to a docosahexaenoic acid (DHA: an ω‐3 polyunsaturated fatty acid (PUFA)) is designed towards the creation of compartmentalized liquid crystalline assemblies of neuroprotective compounds. The hormone PACAP38 is a ligand of the class B PAC1 G‐protein‐coupled receptor (GPCR), whereas DHA is a lipid trophic factor. The lipidated peptide PACAP‐DHA is co‐assembled into hierarchical nanostructures elaborated from hybrid vesicle‐micelle reservoirs as well into PEGylated cubosomes composed of multiple neuroprotective building blocks. The resulting nanostructures are determined by synchrotron small‐angle X‐ray scattering (BioSAXS) and cryogenic transmission electron microscopy (cryo‐TEM). Multicompartment topologies are obtained in a two‐fold approach: (i) intriguing compartmentalized vesicles, which embed pep‐lipid micelles forming nanopatterns, and (ii) multidomain pep‐lipid cubosomes. Both kinds of topologies are favorable for sustained‐release applications in combination therapies of neurodegeneration. The organizational complexity of the scaffolds involving the lipidated high‐molecular weight peptide hormone is beyond the one that has been reached with small lipid‐like peptide surfactants. Abstract : Multicompartment topologies of pep‐lipid cubosomes and vesicles enclosing micelles, co‐assembled with an unusual organizational complexity using multiple neuroprotective building blocks, and suitable as nanostructured membrane‐mimetic environment for the sustained delivery of the class B GPCR ligand Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP38) coupled to the lipid trophic factor docosahexaenoic acid (DHA). … (more)
- Is Part Of:
- ChemNanoMat. Volume 5:Issue 11(2019)
- Journal:
- ChemNanoMat
- Issue:
- Volume 5:Issue 11(2019)
- Issue Display:
- Volume 5, Issue 11 (2019)
- Year:
- 2019
- Volume:
- 5
- Issue:
- 11
- Issue Sort Value:
- 2019-0005-0011-0000
- Page Start:
- 1381
- Page End:
- 1389
- Publication Date:
- 2019-09-25
- Subjects:
- BioSAXS -- cryo-TEM -- cubosome -- lipidated peptide hormone (class B GPCR ligand) -- multicompartment nanostructure
Nanochemistry -- Periodicals
Nanostructured materials -- Periodicals
Nanochemistry
Nanostructured materials
Periodicals
541.2 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2199-692X/issues ↗
http://resolver.library.ualberta.ca/resolver?ctx_enc=info%3Aofi%2Fenc%3AUTF-8&ctx_ver=Z39.88-2004&rfr_id=info%3Asid%2Fualberta.ca%3Aopac&rft.genre=journal&rft.object_id=4200000000000019&rft.issn=2199-692X&rft.eissn=&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&url_ctx_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Actx&url_ver=Z39.88-2004 ↗
http://resolver.lrc.macewan.ca/macewan?url%5Fver=Z39.88-2004&ctx%5Fver=Z39.88-2004&ctx%5Fenc=info:ofi/enc:UTF-8&rfr%5Fid=info:sid/sfxit.com:opac%5F856&url%5Fctx%5Ffmt=info:ofi/fmt:kev:mtx:ctx&sfx.ignore%5Fdate%5Fthreshold=1&rft.object%5Fid=4200000000000019&svc%5Fval%5Ffmt=info:ofi/fmt:kev:mtx:sch%5Fsvc& ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cnma.201900468 ↗
- Languages:
- English
- ISSNs:
- 2199-692X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3172.255010
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12074.xml